Chapter I-i 3. CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED)
- PART 200 [§ 200.5 - § 200.200] - PART 200—GENERAL
- PART 201 [§ 201.1 - § 201.328] - PART 201—LABELING
- PART 202 [§ 202.1 - § 202.1] - PART 202—PRESCRIPTION DRUG ADVERTISING
- PART 203 [§ 203.1 - § 203.70] - PART 203—PRESCRIPTION DRUG MARKETING
- PART 205 [§ 205.1 - § 205.50] - PART 205—GUIDELINES FOR STATE LICENSING OF WHOLESALE PRESCRIPTION DRUG DISTRIBUTORS
- PART 206 [§ 206.1 - § 206.10] -
- PART 207 [§ 207.1 - § 207.81] - PART 207—REQUIREMENTS FOR FOREIGN AND DOMESTIC ESTABLISHMENT REGISTRATION AND LISTING FOR HUMAN DRUGS, INCLUDING DRUGS THAT ARE REGULATED UNDER A BIOLOGICS LICENSE APPLICATION, AND ANIMAL DRUGS, AND THE NATIONAL DRUG CODE
- PART 208 [§ 208.1 - § 208.26] - PART 208—MEDICATION GUIDES FOR PRESCRIPTION DRUG PRODUCTS
- PART 209 [§ 209.1 - § 209.11] - PART 209—REQUIREMENT FOR AUTHORIZED DISPENSERS AND PHARMACIES TO DISTRIBUTE A SIDE EFFECTS STATEMENT
- PART 210 [§ 210.1 - § 210.3] - PART 210—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PROCESSING, PACKING, OR HOLDING OF DRUGS; GENERAL
- PART 211 [§ 211.1 - § 211.208] - PART 211—CURRENT GOOD MANUFACTURING PRACTICE FOR FINISHED PHARMACEUTICALS
- PART 212 [§ 212.1 - § 212.110] - PART 212—CURRENT GOOD MANUFACTURING PRACTICE FOR POSITRON EMISSION TOMOGRAPHY DRUGS
- PART 213 - PART 213—XXX
- PART 216 [§ 216.23 - § 216.24] - PART 216—HUMAN DRUG COMPOUNDING
- PART 225 [§ 225.1 - § 225.202] - PART 225—CURRENT GOOD MANUFACTURING PRACTICE FOR MEDICATED FEEDS
- PART 226 [§ 226.1 - § 226.115] - PART 226—CURRENT GOOD MANUFACTURING PRACTICE FOR TYPE A MEDICATED ARTICLES
- PART 230 - PART 230—XXX
- PART 250 [§ 250.11 - § 250.250] - PART 250—SPECIAL REQUIREMENTS FOR SPECIFIC HUMAN DRUGS
- PART 251 [§ 251.1 - § 251.21] - PART 251—SECTION 804 IMPORTATION PROGRAM
- PART 290 [§ 290.1 - § 290.10] - PART 290—CONTROLLED DRUGS
- PART 299 [§ 299.3 - § 299.5] - PART 299—DRUGS; OFFICIAL NAMES AND ESTABLISHED NAMES